Skip to content

    CHAMPIONS ONCOLOGY (CSBR) stock price & financials

    View CSBR earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance25.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $14.06M
    $13.49M
    $17.04M
    $12.36M
    $13.99M
    -0.5%
    $15.04M
    +11.5%
    $16.56M
    -2.8%
    $13.84M
    +12.0%
    Strengthening
    Operating Profit
    $1.33M
    $732.0K
    $4.50M
    -$2.01M
    -$527.0K
    -139.7%
    $185.0K
    -74.7%
    -$276.0K
    -106.1%
    -$522.0K
    +74.0%
    Weakening
    Net Profit
    $1.31M
    $728.0K
    $4.50M
    -$1.83M
    -$436.0K
    -133.2%
    $268.0K
    -63.2%
    -$279.0K
    -106.2%
    -$728.0K
    +60.3%
    Weakening
    EPS
    $0.10
    $0.05
    $0.33
    $-0.03
    -130.0%
    $0.02
    -60.0%
    $-0.02
    -106.1%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    $1.33M
    $739.0K
    $4.52M
    -$1.97M
    -$452.0K
    -133.9%
    $255.0K
    -65.5%
    -$237.0K
    -105.2%
    -$495.0K
    +74.8%
    Weakening
    MarginsOPM
    9.4%
    5.4%
    26.4%
    -16.2%
    -3.8%
    -139.9%
    1.2%
    -77.3%
    -1.7%
    -106.3%
    -3.8%
    +76.8%
    Weakening
    Tax
    1.6%
    1.5%
    0.5%
    6.6%
    -3.1%
    -297.5%
    7.1%
    +373.8%
    -17.7%
    -3574.5%
    -34.8%
    -624.9%
    Weakening
    ReturnsROIC
    -1.6%
    -0.9%
    -5.5%
    2.3%
    0.5%
    -0.3%
    +63.2%
    0.3%
    0.9%
    -60.3%
    Stable

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26
    AssetsCash & Equivalents$3.24M$8.34M$4.69M$9.01M$10.12M$2.62M$9.79M$4.87M
    Short-Term Investments
    Total Current Assets$7.92M$13.50M$12.63M$19.66M$19.46M$13.64M$22.36M$19.22M
    Net PP&E$2.55M$6.79M$14.61M$15.36M$14.50M$11.97M$9.46M$7.22M
    Goodwill$669.0K$335.0K$335.0K$335.0K$335.0K$335.0K$335.0K$335.0K
    Intangibles
    Total Assets$11.27M$20.75M$27.59M$35.38M$34.31M$26.13M$32.34M$26.99M
    LiabilitiesTotal Current Liabilities$8.03M$12.30M$11.20M$17.48M$21.73M$21.54M$23.85M$19.92M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$3.17M$8.78M$8.41M$7.39M$6.09M$4.63M$2.99M
    Total Liabilities$9.03M$15.65M$20.16M$26.28M$29.68M$28.04M$28.57M$22.92M
    EquityCommon Stock & APIC$12.0K$13.0K$13.0K$14.0K$14.0K$14.0K$14.0K$14.0K
    Retained Earnings-$70.70M-$72.89M-$72.53M-$71.98M-$77.32M-$84.59M-$79.89M-$81.07M
    Total Equity$2.14M$5.10M$7.43M$9.10M$4.64M-$1.90M$3.77M$3.94M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26
    ActivitiesCash from Operating$1.86M$2.90M-$1.68M$6.50M$3.97M-$6.14M$7.39M-$4.47M
    Cash from Investing-$834.0K-$2.22M-$3.17M-$2.38M-$2.87M-$836.0K-$389.0K-$540.0K
    Cash from Financing$1.20M$4.42M$1.20M$207.0K$11.0K-$527.0K$170.0K$99.0K
    SummaryCapital Expenditure-$834.0K-$2.22M-$3.28M-$2.38M-$2.87M-$836.0K-$389.0K-$564.0K
    Free Cash Flow$1.03M$685.0K-$4.96M$4.11M$1.10M-$6.97M$7.00M-$5.04M
    FCF Margin35.4%2.1%-12.1%8.4%2.0%-13.9%12.3%-8.5%

    Ratios